Double blind randomized clinical trial controlled by placebo with a FOS enriched cookie on saciety and cardiovascular risk factors in obese patients

被引:11
|
作者
de Luis, D. A. [1 ,2 ]
de la Fuente, B. [1 ,2 ]
Izaola, O. [1 ,2 ]
Aller, R. [1 ,2 ]
Gutierrez, S. [3 ]
Morillo, Maria [4 ]
机构
[1] Univ Valladolid, Fac Med, Inst Endocrinol & Nutr, Simancas 47130, Valladolid, Spain
[2] Univ Valladolid, Hosp Rio Hortega, Unidad Apoyo Invest, Simancas 47130, Valladolid, Spain
[3] CARTIF, Div Invest Gullon SA, Valladolid, Spain
[4] CARTIF, Div Aliment, Valladolid, Spain
关键词
Cardiovascular risk factors; Cookies; FOS; Satiety; Obesity; OLIGOFRUCTOSE PROMOTES SATIETY; MEAL INTAKE; HIGH-FAT; APPETITE; ENERGY; FOOD; SNACK; DIET; AIR;
D O I
10.3305/nh.2013.28.1.6255
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Introduction: It is essential to determine which snack foods are most affective for appetite control. The objective of the current study was to assess the responses of two different cookies on satiety and cardiovascular risk factors. Material and Methods: 38 patients were randomized: group I (FOS enriched cookie, n=19) and group II (control cookie, n=19). Previous and after 1 month, the subjects rated their feelings of satiety/hunger with a test meal of 5 cookies. Results: After the test meal, the basal area under curve of the first hunger/satiety score was higher with satiety cookie than with control cookie, the data after 1 month of treatment was higher with satiety cookie than with control cookie, too. The score was higher than the fasting level for 20 minutes with satiety cookie and for 40 minutes with the same cookie, too. In satiety group, these scores (20 min and 40 min) were higher than control group before and after 1 month of treatment. The results were in the same way with the 100 mm 5-point visual satiety scale. Cardiovascular risk factors and dietary intake remained unchanged after dietary intervention. Conclusion: A FOS enriched cookie produced greater ratings of satiety than a control cookie, without effects on cardiovascular risk factors or dietary intakes. (Nutr Hosp. 2013;28:78-85) DOI:10.3305/nh.2013.28.1.6255
引用
收藏
页码:78 / 85
页数:8
相关论文
共 50 条
  • [31] Effects of red ginseng supplementation on menopausal symptoms and cardiovascular risk factors in postmenopausal women: a double-blind randomized controlled trial
    Kim, Sun Young
    Seo, Seok Kyo
    Choi, Young Mi
    Jeon, Young Eun
    Lim, Kyung Jin
    Cho, SiHyun
    Choi, Young Sik
    Lee, Byung Seok
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2012, 19 (04): : 461 - 466
  • [32] Gabapentin before laparoscopic sleeve gastrectomy reduces postoperative oxycodone consumption in obese patients: a randomized double-blind placebo-controlled trial
    Rupniewska-Ladyko, Anna
    Malec-Milewska, Malgorzata
    Kraszewska, Ewa
    Pirozynski, Michal
    MINERVA ANESTESIOLOGICA, 2018, 84 (05) : 565 - 571
  • [33] Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: a double blind, placebo controlled randomized trial
    Verhoeven, Veronique
    Van der Auwera, Anastasia
    Van Gaal, Luc
    Remmen, Roy
    Apers, Sandra
    Stalpaert, Michel
    Wens, Johan
    Hermans, Nina
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 15
  • [34] Quercetin supplementation in non-alcoholic fatty liver disease A randomized, double-blind, placebo-controlled clinical trial
    Hosseinikia, Mahboobe
    Oubari, Farhad
    Hosseinkia, Roghaye
    Tabeshfar, Zibaneh
    Salehi, Mohammad Gharib
    Mousavian, Zeinab
    Abbasi, Mehrnaz
    Samadi, Mehnoosh
    Pasdar, Yahya
    NUTRITION & FOOD SCIENCE, 2020, 50 (06) : 1279 - 1293
  • [35] Effectiveness of acupuncture and a cumin-based herbal formula on anthropometric indices of overweight patients: a randomized double-blind placebo-controlled clinical trial
    Adel-Mehraban, Mohammad Sadegh
    Karimi, Mehrdad
    Alipour, Reihane
    Mirali, Zahra
    Ghaem, Haleh
    Zargaran, Arman
    Mirzaei, Khadijeh
    Kazemi, Amir Hooman
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2024, 23 (02) : 2329 - 2341
  • [36] Exploring the efficacy and safety of herbal medicine on Korean obese women with or without metabolic syndrome risk factors A study protocol for a double-blind, randomized, multi-center, placebo-controlled clinical trial
    Ko, Youme
    Kim, Hyun-Ju
    Kim, Hojun
    Choi, Jin-Bong
    Kwon, Young-Dal
    Jung, Won-Seok
    Jang, Bo-Hyoung
    Kim, NamKwen
    Song, Yun-Kyung
    Ko, Seong-Gyu
    MEDICINE, 2020, 99 (28) : E21153
  • [37] Zonisamide for Bipolar Depression: A Randomized, Double Blind, Placebo-Controlled, Adjunctive Trial
    Dauphinais, Deborah
    Knable, Michael
    Rosenthal, Joshua
    Polanski, Mark
    Rosenthal, Norman
    PSYCHOPHARMACOLOGY BULLETIN, 2011, 44 (02) : 73 - 84
  • [38] Preoperative Multistrain Probiotic Supplementation Does Not Affect Body Weight Changes or Cardiometabolic Risk Factors in Bariatrics: Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Potrykus, Marta
    Czaja-Stolc, Sylwia
    Stankiewicz, Marta
    Szymanski, Michal
    Loniewski, Igor
    Kaska, Lukasz
    Proczko-Stepaniak, Monika
    NUTRIENTS, 2024, 16 (13)
  • [39] Effects of synbiotic supplementation on anthropometric indices and body composition in overweight or obese children and adolescents: a randomized, double-blind, placebo-controlled clinical trial
    Atazadegan, Mohammad Amin
    Heidari-Beni, Motahar
    Entezari, Mohammad Hassan
    Sharifianjazi, Fariborz
    Kelishadi, Roya
    WORLD JOURNAL OF PEDIATRICS, 2023, 19 (04) : 356 - 365
  • [40] Efficacy and tolerability of a novel herbal formulation for weight management in obese subjects: a randomized double blind placebo controlled clinical study
    Krishanu Sengupta
    Atmatrana T Mishra
    Manikeswar K Rao
    Kadainti VS Sarma
    Alluri V Krishnaraju
    Golakoti Trimurtulu
    Lipids in Health and Disease, 11